Beta‐blockers for hypertension
175 results
101 - 175
Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices- Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials: Cochrane systematic review
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
Chronic heart failure 
Treatment for mild hypertension is ineffective- First‐line drugs for hypertension
- Choice of prophylactic medication for atrial fibrillation - Image
- Guideline for the management of heart failure: early prevention for patients at risk, quadruple therapy for those with symptoms
- Beta-blockers associated with improved morbidity/mortality in COPD patients
- JNC 8 report on prevention/evaluation/treatment of hypertension
- Prevention of atrial fibrillation
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Antihypertensive drugs and incident diabetes
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- Lowering blood pressure does not decrease the risk of T2DM in persons with hypertension; ACEIs/ARBs do
- Choice of antihypertensive drug in the diabetic patient from prognostic point of view
- Alcohol or drug intoxication
- Erectile dysfunction
- BP lowering by any means is beneficial in most
- Exercise stress test
- Medical treatment of glaucoma and intraocular hypertension
- Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
- Acute coronary syndrome
- Vasoactive drugs for acute ischaemic stroke
- Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD
- Primary hyperaldosteronism (PHA)
- Evening versus morning dosing of antihypertensive drugs
- Pharmacotherapy for hypertension in adults aged 18 to 59 years
- Diabetic kidney disease (diabetic nephropathy)
- In hypertensive CKD, intensive BP control only helpful for higher risk patients
- Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an acute cardiovascular event
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension: Cochrane systematic review
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Lower limb ischaemia
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- ACE = ARB for secondary CV prevention; combination worse (ONTARGET)
- ACC/AHA guidelines for atrial fibrillation
- COVID-19 research briefs: Antihypertensive use not associated with an increased risk of SARS-CoV-2 infection
- Interventions for preventing and managing advanced liver disease in cystic fibrosis
- Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- NSAIDs and blood pressure
- Spironolactone for hypertension
- Raynaud's phenomenon (RP) or white finger disease
- Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Identification of illegal drug overdose and diagnosis of illegal drug poisoning
- Preoperative assessment
- Turner syndrome
- Prehospital emergency care
- The most common types of acquired adult valvular heart disease and associated murmurs
- Cirrhosis of the liver
- Aortic stenosis
- Platelet count, spleen length, and platelet count‐to‐spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Aortic aneurysm and dissection
- Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis
- Treatment of chronic renal failure
- Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension
- Interventions for fatigue in people with kidney failure requiring dialysis
- Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews
- Use of medication during pregnancy